4th Annual Cancer Control Symposium: Cancer Screening - Too Much, Too Little, or Just Right?

Friday, March 15, 2019
Bell Harbor International Conference Center
Harbor Room
2211 Alaskan Way
Seattle, Washington 98121


Screening increases the chances of detecting certain cancers early, when they might be easier to treat. However, there are often conflicting or changing screening recommendations, along with other barriers to patients, which may result in low community screening rates. Based on a recent community health needs assessment focused on cancer, it was determined there is a need to improve screening rates for those at-risk for cancer, dispel screening myths and misinformation, enhance screening processes, and make sure the most up-to-date screening information is available and practiced among health care professionals. Addressing these needs will result in more accurate screening recommendations for patients and improved cancer detection.

Swedish Cancer Institute's 4th Annual Cancer Control Symposium will feature didactic lectures and discussions about screenings for multiple cancer sites, and review the current recommendations and the resulting rates in our communities. Specifically, this course will include lectures focused on colon, breast and HPV-related cancers as well as addressing the solutions (such as primary care processes) to improve screening rates.

This conference is intended for all health-care professionals involved in the care of cancer patients and those at risk, including physicians, ARNPs, PAs, nurses, pharmacists, allied health professionals, administrative leaders, community program managers, patient health advocates, residents/fellows and researchers. It is especially relevant for the following specialties: medical oncology, radiation oncology, surgical oncology, genetic counseling, family medicine, internal medicine, primary care, research, palliative care, community public health, supportive care services, and social work.

Registration is closed. Walk-ins are welcome.

Faculty

Thomas D. Brown, M.D., MBA.
Executive Director
Swedish Cancer Institute

Christopher Dale, M.D.
Chief Quality Officer
Swedish Medical Group

Casey Eastman
Breast, Cervical and Colon Health Programs
Washington State Dept. of Health

J. Blake Golden, M.D., FACS
Head and Neck Surgeon
Otolaryngologist
Swedish Cancer Institute

Gary Goodman, M.D., MS
Medical Oncologist
Senior Investigator
Swedish Cancer Institute
Member, Cancer Prevention Program
Public Health Sciences Division
Fred Hutchinson Cancer Research Center

Paula Hallam, M.D.
Medical Director
Swedish Breast Imaging -First Hill
Swedish Cancer Institute

Gary E. Heyamoto, DDS
National Academy of General Dentistry
Washington State Dental Association
Washington State HPV Task Force

M. Peter Lance, M.D., FRCP
Professor, Medicine
Professor, Public Health
Professor, Molecular and Cellular Biology
University of Arizona College of Medicine
Co-Director
Cancer Prevention and Control
University of Arizona Cancer Center

Richard McGee, M.D.
True North Oncologyr

Shilpen Patel, M.D., FACRO, FASTRO
Medical Director
Grail, Inc.

Scott Ramsey, M.D., Ph.D.
Director, Hutchinson Institute for Cancer Outcomes Research (HICOR)
Full Member, Public Health Services
Fred Hutchinson Cancer Research Center
Professor, University of Washington School of Medicine

Jill Wruble, D.O.
Assistant Clinical Professor of Radiology
Yale School of Medicine
UCONN School of Medicine

Sherri Zorn, M.D.
Pediatrician
Vaccine Champion at Polyclinic Pediatrics
The Polyclinic

Swedish CME maintains full control of the content of every course we provide. It is our policy to identify and resolve all speaker and planner conflicts of interest. Each speaker is required to give a balanced, evidence-based presentation that is free of commercial bias.

Planning Committee

Somasundaram Subramaniam, M.D., MS, Course Director
Thomas Brown, M.D., MBA
Gary Goodman, M.D., MS
Paul Kilian, MBA
Barbara Kollar, MHA, MCHES
Cecilia Lynn, ARNP
Susan Montgomery, M.D.
Kathleen To
Nancy Thompson, MSN, RN
Kristin Wisegarver, MHA
Caye Boosalis, MEd, CME Manager
Danielle Posadas, CME Specialist Sr.

Agenda

Objectives

At the conclusion of this symposium, the participant will provide better patient care through an increased ability to:

Overall Course

  • Review the current state of cancer screenings and future implications
  • Recognize the impact of screenings in cancer prevention and the resulting outcomes of low screening rates for certain cancers
  • Provide correct cancer screening recommendations to at-risk patient populations based on current guidelines
  • Discuss and apply process improvements for cancer screenings in primary care and steps to optimize the cancer screening process to improve patient outcomes
  • Use community and organizational resources to reduce barriers to screenings (such as culture, language, location, and cost)

Lecture Specific

  • Discuss the frequency of false positive screening tests, review the significance of 5 year survival data in the context of screening, and interpret data reported in relative and absolute terms
  • Review current methods for colorectal cancer screening and relative effect sizes, apply approaches to tailoring colorectal cancer screening to population and individual, and discuss future approaches such as risk profiling and complex datasets
  • Review 2D and 3D mammography options for breast cancer screening, discuss the TMIST trial, and perform a high-risk assessment for Breast Cancer
  • Discuss with experts the relevance of screenings in the cancer continuum and how getting the right test at the right time can affect cancer outcomes
  • Articulate different sources of cancer screening guidelines, recognize an approach to pathway creation and curation, and apply a model for quality improvement involving clinical pathways in a practice environment
  • Discuss patient barriers to screenings such as cost and coverage and debate the responsibility of screening cost in the healthcare environment with local experts
  • Describe the impact of HPV vaccine on preventing HPV infection and HPV-related cancers, provide a strong and effective recommendation to patients and their families for HPV immunization, and implement practical strategies to track and increase HPV immunization rates
  • Discuss the impact of HPV on prevention and screening of related cancers with local experts
  • Recognize potential new screening options for patients, discuss the importance of early diagnosis, and use knowledge of future screening options to enhance cancer awareness and make a difference in the community

Credit

Accreditation with Commendation
Swedish Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Category 1 Credits
Swedish Medical Center designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
AMA PRA Category 1 Credits™ are accepted for Washington State RN Continuing Education requirements as well as for application and renewal of specialty and advance practice certification through both ANCC and AANP (1 CNE hour is equivalent to 1 CME hour).

Genetic Counselor CEUs
The National Society of Genetic Counselors (NSGC) has authorized Swedish Medical Center  to offer up to 0.6 CEUs or 6 Category 1 contact hours for the activity 4th Annual Cancer Control Symposium: Cancer Screening - Too Much, Too Little, or Just Right?. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
NSGC User IDs are required for all participants wishing to claim CEUs. If needed, please find or create a free or paid NSGC User ID at www.nsgc.org.

National Commission for Health Education Credentialing
Sponsored by Swedish Medical Center, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 6 total Category I continuing education contact hours. Maximum entry level continuing education contact hours available are 6.

Details

Despite decades of cancer care, public communication campaigns and prevention techniques there are still many gaps in cancer care at various points within the continuum from cancer prevention, early detection, diagnosis, treatment, survivorship and end-of life care.

Based on a recent community health needs assessment focused on cancer, it was determined there is a need to improve screening rates for those at-risk for cancer, dispel screening myths and misinformation, enhance screening processes, and make sure the most up-to-date screening information is available and practiced among health care professionals. Addressing these needs will result in more accurate screening recommendations for patients and improved cancer detection.

Through didactic lectures, multidisciplinary panels and cancer control case examples, this symposium will review the tools and techniques that can be used by health care professionals to improve screening rates for cancers among at-risk populations and lessen confusion about current screening recommendations.

Fees

  Advance
Registration
M.D./D.O.  $235*
Swedish M.D./D.O. $205*
Allied Health Professionals (Non-Swedish, need credit; ARNP, PA, etc.) $120*
Swedish Allied Health Professional (need credit; ARNP, PA, etc.) $90*
Swedish Employees (no CME credit needed, not in above categories) $50
Community Health Organizations / Patient Advocates $50
Residents/Fellows/Medical Students Please contact
Swedish CME to register.

*After Monday, March 4, please add $30 to Advance Registration pricing.

Registration Information
Pre-registration is required as space is limited. Participants who register by the "Advance Registration" date will receive a reminder email after Monday, March 4, 2019. Registrations will only be processed when accompanied by full payment.

Cancellation
To receive a refund, notice of cancellation must be received no later than Friday, March 8, 2019.

Special Accommodations
If you require specific dietary or physical accommodations, please contact Swedish CME at cme@swedish.org or 206-386-2755.

Registration Fees
Swedish CME is a self-sustaining unit and does not depend on or receive public monies in support of its educational efforts. The fees for this course includes catering, all instruction materials, wi-fi access, online syllabus access and a certificate of AMA PRA Category 1 Credits™.

Acknowledgments
This symposium is financially supported in part by educational grants in accordance with ACCME’s Standards for Commercial Support. A complete listing of commercial supporters is not available at this time. Appropriate acknowledgment will be given to all supporters at the time of the symposium.

Acknowledgement

The planning committee gratefully acknowledges the Platinum Level exhibit support for this conference from:

Amgen

Merck Oncology

Myriad Genetics